The Swiss pharmaceutical giant Roche on Tuesday begins a two-day appeal asking the US Food and Drug Administration to allow the top-selling drug Avastin to be used for breast cancer.
Roche appeals FDA move against cancer drug Avastin
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.